RxDoctor Payments Data

Todd Clarkson, DO

General Practice · Seminole, FLNPI 1033210745

Payments from drug & device makers

$875in general payments, 2019–2025

Across 44 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$199
  • Lilly USA, LLC$144
  • Bayer$121
  • AbbVie$117
  • Dexcom, Inc.$96
  • Novo Nordisk$42
  • plus $155 from 8 others

What the payments were for

  • Food & beverage$875100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$875 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$44,955
Medicare patients
158
Services billed
662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban93$86,834
OzempicSemaglutide55$49,395
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$40,918
XareltoRivaroxaban32$31,764
JardianceEmpagliflozin16$22,014
Breo ElliptaFluticasone/Vilanterol34$19,707
MounjaroTirzepatide13$15,251
TrulicityDulaglutide11$14,070
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$12,278
Albuterol Sulfate HfaAlbuterol Sulfate197$5,546
Levothyroxine Sodium410$4,492
SymbicortBudesonide/Formoterol Fumarate16$4,005
Fluticasone Propionate72$3,680
LantusInsulin Glargine,hum.Rec.Anlog15$3,445
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$86,83493 claims
GSKTrelegy Ellipta, Breo Ellipta$199$60,62582 claims
Novo NordiskOzempic$42$49,39555 claims
Johnson & JohnsonXarelto$34$31,76432 claims
Lilly USA, LLCMounjaro, Trulicity$144$29,32124 claims
AstraZenecaBreztri Aerosphere, Symbicort$19$16,28430 claims
AbbVieSynthroid$117$1,21918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,901 general practice providers in Florida.

Other general practice in Seminole

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →